Cigarette smokers inhale a broad range of carcinogens derived from tobacco and its pyrolysis products, including free radicals, which induce oxidative stress and subsequent lipid peroxidation (LPO). Miscoding carcinogen-DNA adducts are formed by cigarette smoke constituents and are thought to initiate lung carcinogenesis. The presence of various types of DNA damage was therefore analyzed in tumor adjacent uninvolved lung tissues of 13 smoking and 11 non-smoking operated lung cancer patients. 
Introduction
Cigarette smoking is causally associated with the development of pre-neoplastic biochemical changes in human lung (1) and lung cancer (2) . It is hypothesized that the mechanism of tobacco smoke-induced lung cancer varies according to the location and histological type of the tumor. The deposition of cigarette smoke particulates containing polycyclic aromatic hydrocarbons (PAH) in the major lung bronchi probably initiates the formation of squamous cell carcinoma at that site. Many researchers have focused on the role of PAH-induced DNA damage in the induction of lung cancer (3) (4) (5) (6) . The reactive metabolite of the well studied benzo[a]pyrene, benzo [a] pyrene-diol epoxide (BPDE), was found to bind to a specific hotspot in the p53-gene, which has been found to be frequently mutated in human lung cancer (3) and aromatic-DNA adduct levels were found to correlate with lung cancer risk in a recent prospective molecular epidemiological study (4) .
On the basis of decreasing concentrations of tar that contains benzo [a] pyrene and other PAH, and increasing levels of alkylating compounds such as tobacco-specific nitrosamines (TSNA) in cigarette smoke, it is plausible that alkylating carcinogens are partially responsible for the rise in the incidence of lung adenocarcinoma, which has now surpassed squamous cell carcinoma as the leading type of lung cancer (7) . Tobacco smoke-derived alkylating compounds covalently bind to DNA in the lung and their mutagenic potency depends mainly on the position of binding within the four DNA bases: O-substitution by alkylating agents results in relevant DNA adducts in terms of mutagenesis and carcinogenesis, including O 6 -alkylguanine and O 4 -alkylthymine (8) . Cigarette smoke contains ethylating compounds, such as N-nitrosodiethylamine (NDEA) and hitherto uncharacterized ethylating agents, since increased levels of N-ethylated DNA bases have been reported in urine of smokers as compared with non-smokers (9) (10) (11) . Animal studies indicated that after exposure to ethylating compounds, O 4 -ethylthymidine (O 4 etT) is initially formed in very low levels, but is poorly repaired and thus accumulates to biologically relevant levels (12) . Our newly developed method for the detection of O 4 etT made it now possible to study the formation of O 4 etT in human lung of smoking and non-smoking subjects (13) .
The role of continuous exposure to tobacco smoke-derived free radicals in the onset or progression of lung cancer still needs further attention. Free radicals may enhance lipid peroxidation (LPO) in the lung by which reactive unsaturated aldehydes are generated (14) . Further oxidation of the aldehyde 4-hydroxy-2-nonenal leads to the formation of 2,3-epoxy-4-hydroxynonanal, a bifunctional alkylating agent which can react with DNA to yield etheno-DNA adducts, including 1,N 6 -ethenodeoxyadenosine (εdA) and 3,N 4 -ethenodeoxycytidine (εdC). Etheno-DNA adducts are highly miscoding lesions in mammalian cells and are thought to initiate the carcinogenic process through specific point mutations, as shown for the known carcinogen vinyl chloride (15) . However, no information is available yet on the presence and levels of these etheno-DNA adducts in human lung.
In the present study, a direct comparison has been made R.Godschalk et al. between the persistence of DNA adducts by different classes of tobacco smoke-derived carcinogens in lung tissue of smoking and non-smoking lung tumor patients. We investigated by 32 P-postlabeling, the formation of aromatic-DNA adducts, O 4 etT, and adducts formed by LPO products, εdA and εdC in tumor adjacent, uninvolved lung tissue of smoking and nonsmoking operated lung tumor patients.
Materials and methods
Characteristics of study-subjects Adjacent non-tumorous lung tissues from 13 smoking and 11 non-smoking lung tumor patients (mean age 61 Ϯ 9, 15 male/nine female) were collected at surgery for lung tumor resection. Histological types of lung cancer were determined by the hospital pathologists. Tissue samples were frozen in liquid nitrogen immediately after surgery, and stored at -80°C. Smoking information was obtained from the patient by questionnaire. The study was approved by the ethical committee of the University of Heidelberg (no. 182/96). The overall characteristics of the study subjects are given in Table I .
DNA isolation procedure from human lung samples
Approximately 80 mg of tissue was homogenized in lysis-buffer (DNAisolation kit supplied by Qiagen, Hilden, Germany) using a polytron homogenizer (15 000 r.p.m. for~30 s). Proteinase K and RNases were added, followed by a 2 h incubation at 50°C. Subsequently, DNA was isolated using Qiagen columns according to the manufacturer's protocol with the following modification of the supplied elution buffer; pH was set to 7.4 and the NaCl concentration was increased to 1.4 M. DNA was precipitated by the addition of 0.7 volume isopropanol, collected by centrifugation, washed twice with 70% ethanol and dried in vacuo. Before analysis, DNA was redissolved in water and quantified by spectrophotometry at 260 nm.
Adduct analyses by 32 P-postlabeling O 4 -ethylthymidine. O 4 etT was analyzed according to Godschalk et al. (13) . Briefly, DNA (25 µg) was digested into nucleotide monophosphates by micrococcal nuclease and spleen phosphodiesterase followed by immunoprecipitation of O 4 etT with saturated ammonium sulfate using the specific antibody ER-01. Normal nucleotides were quantified by HPLC-UV analysis of the supernatants after adduct precipitation. The antibody-adduct interaction product was collected by centrifugation, redissolved in 400 µl water and transferred into a microcon centrifugation filter (MY-50, molecular weight cut-off: 50 000 Da), which retains the antibody-adduct complex. Filters were washed five times with water and the remnants collected by inversion of the filter and short centrifugation (10 000 r.p.m. for 5 min). Proteins were precipitated by the addition of 500 µl cold ethanol and the supernatants were dried and stored at -80°C. Internal standard (800 attomol εdA) and 4 µl kinase buffer were added to the dried enriched samples. After addition of 2 µl of [γ-32 P]ATP (20 µCi), 10 U T4-PNK were added and the mixture was incubated for 2 h at 37°C. Another 10 U T4-PNK were added after 1 h of incubation. Polyethyleneimine (PEI) minicolumns were prepared by filling 2.5 mg PEI into a 200 µl pipet-tip closed with a small frit. The labeled samples were pipetted on top of the PEI and centrifuged for 5 min at 10 000 r.p.m. at 4°C. The labeled adducts were eluted with 5ϫ25 µl 1 M acetic acid, whereas excess ATP bound to the PEI. The eluent was injected into a C18-
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HPLC with online detection of radioactivity. The mobile phase consisted of 100 mM ammonium formate pH 7.5 with 5% MeOH during the first 12 min at a flow rate of 1 ml/min. Then, the methanol concentration was increased to 20% over an 8 min time period (from 12 to 20 min) and further increased to 50% over a period of 10 min (from 20 to 30 min). The internal standard eluted at 17 min and O 4 etT-5Ј 32 P-monophosphate at 22 min, whereas residual normal nucleotides eluted before 12 min as shown in Figure 1A (sample) and D (standard).
1,N 6 -ethenodeoxyadenosine (εdA), 3,N 4 -ethenodeoxycytidine (εdC)
. εdA and εdC were analyzed in DNA by immunoaffinity/ 32 P-postlabeling (15) . In brief, 25 µg of DNA was hydrolyzed to nucleotide 3Ј-monophosphates using micrococcal nuclease and spleen phosphodiesterase. Normal nucleotides were quantified by high-performance liquid chromatography of part of the digest and the adducts were enriched on immunoaffinity columns prepared from the monoclonal antibodies EM-A-1 (εdA) and EM-C-1 (εdC). The antibodies used in this study were provided by M.Rajewsky (Institute of Cell Biology, University of Essen, Essen, Germany); their characteristics have been reported previously. The adducts and the internal standard deoxyuridine 3Ј-monophosphate were labeled with [γ-32 P]ATP (Ͼ5000 Ci/mmol) and T4 polynucleotide kinase (Amersham Buchler, Braunschweig, Germany and Pharmacia Biotech, Freiburg, Germany, respectively). The adducts were resolved on polyethyleneimine-TLC plates using two-directional chromatography [D1 ϭ 1 M acetic acid (pH 3.5), D2 ϭ saturated ammonium sulfate (pH 3.5)]. After autoradiography, the adduct spots and the internal standard were marked, cut, and the radioactivity was measured in a liquid scintillation counter. The absolute adduct levels were quantified using standards, and the relative adduct level per parent nucleotides was determined with the amount of deoxycytidine (dC) and deoxyadenosine (dA) obtained from high-performance liquid chromatography analysis of normal nucleotides obtained from the DNA digest. Typical chromatograms are shown in Figure 1B (sample) and E (standard).
Aromatic-DNA adducts. DNA (~10 µg) was digested into nucleotide monophosphates and treated with nuclease P1 for 40 min at 37°C (16) . Then, nucleotides were 5Ј-labeled with 32 P using T4-polynucleotide kinase (5.0 U) for 30 min at 37°C. Radiolabeled adduct nucleotide biphosphates were separated by chromatography on PEI-cellulose sheets (Macherey Nagel, Germany Figure 1C (sample) and F (standard). Adducts were quantified as total aromatic-DNA adducts (total radioactivity) and as putative BPDE-DNA adducts (radioactivity at chromatographic location of BPDE-DNA).
Statistics
Data are presented as means (ϮSD). Non-parametric tests were used to assess statistical significances; the Mann-Whitney U-test was used to assess differences between DNA adduct levels in smokers and non-smokers and the Friedman test for paired samples was used to assess differences between the levels of various DNA adduct types. Adduct levels of samples in which no adducts were detectable, were arbitrarily set on half of the detection limit. Relationships between DNA adduct levels were determined by simple regression analysis. P Ͻ 0.05 was considered statistically significant. typical for exposure to complex chemical mixtures. Faint DRZs were found in non-tumorous tissue of five out of 11 non-smoking subjects. Total aromatic-DNA adduct levels were significantly higher in smoking lung cancer patients as compared with non-smoking patients (11.2 Ϯ 7.8 adducts/10 8 nucleotides and 2.2 Ϯ 2.2, respectively, P ϭ 0.001, Table II) . A positive correlation was observed between aromatic-DNA adducts and O 4 etT, indicating that both were formed from the same source of exposure, i.e. cigarette smoke (r ϭ 0.66, P Ͻ 0.01, Figure 2 , smokers and non-smokers combined). This relationship was also found after exclusion of nonsmokers from the analysis (r ϭ 0.54, P ϭ 0.05). To get an impression of the BPDE-DNA adduct level, DNA adducts that migrated at the position of BPDE-DNA were additionally quantified. Putative BPDE-DNA adduct levels were 1.5 Ϯ 1.0/10 8 nucleotides in smoking subjects and 0.2 Ϯ 0.2 in nonsmokers (P Ͻ 0.001), which is most probably an overestimation of the actual BPDE-DNA adduct level, because other adducts may co-migrate during TLC. Etheno-DNA adducts in human lung εdA and εdC levels were not influenced by smoking behavior (Table II) , but were highly interrelated (R ϭ 0.76, P Ͻ 0.001), suggesting that both adduct types were formed by similar pathways. Median εdA levels were 9.2 adducts/10 9 parent nucleotides (range 2.6-146) and 9.4 (range 2.4-56.5) in nonsmokers and smokers, respectively. Median εdC levels were 19.7/10 9 parent nucleotides (range 1.6-395.5) and 9.8 (range 5.8-80.9) in non-smokers and smokers, respectively. Large inter-individual variations were observed; εdA levels ranged from 1.8 to 146.0 adducts/10 9 parent nucleotides (80-fold difference), whereas εdC levels ranged from 1.6 to 395.5 adducts/10 9 parent nucleotides (250-fold difference). Interestingly, these inter-individual variations were much higher in non-smokers (56-and 250-fold for εdA and εdC, respectively) than in smokers (31-and 19-fold for εdA and εdC, respectively). Etheno-DNA adduct levels were not related to age, gender, histological tumor-type or tumor-stage.
Results

O 4 etT in human lung
Adduct abundancy
For reasons of comparison, the relative adduct levels of all adduct types were calculated as adducts per total nucleotides (Table II) . O 4 etT levels were 0.5 Ϯ 0.4 adducts/10 8 nucleotides and 1.2 Ϯ 0.6 for non-smokers and smokers, respectively. Quantification of aromatic-DNA adducts that migrated at the position of BPDE-DNA in smokers resulted in mean levels of 1.5 Ϯ 1.0 adducts/10 8 nucleotides (range Ͻ0.1-2.6), which was not statistically different as compared with the levels of O 4 etT in the same individuals (range 0.6-2.5). When ε-DNA adduct levels were also expressed as adducts per 10 8 total nucleotides, εdA levels were found to be 1.0 Ϯ 1.6 in non-smokers (range 0.1-4.3) and 0.5 Ϯ 0.5 in smokers (range 0.1-1.5), which was different from the levels of O 4 etT and putative BPDE-DNA in smokers, but not in non-smokers. For εdC similar results were found (Table II) . In all smokers and non-smokers, BPDE-DNA like adducts, O 4 etT and etheno-DNA adducts were detected at similar levels in lung DNA (Table II) .
Discussion
Several studies indicated that the formation of PAH-DNA adducts, particularly BPDE-DNA, in human lung is involved in tobacco smoke-induced lung carcinogenesis (3, 4) . In the present study total aromatic-DNA adducts and putative BPDE-DNA adducts were found to be higher in smokers than in nonsmokers by 32 P-postlabeling. In other studies on PAH-DNA adducts in human lung, similar results were obtained by 32 P-postlabeling (5, 6, 17, 18) , but the quantitative aspects should be regarded with some caution, because of uncertainties in the efficiency of 32 P-labeling, recovery and identification of adducts. Nonetheless, putative BPDE-DNA adduct levels as determined in the present study are comparable with those levels reported for human lung using an HPLC-fluorescence detection methodology, with which specific BPDE-DNA adducts can be detected and quantified (19, 20) . Our newly developed methodology to measure O 4 etT in small quantities of DNA enabled the analysis of human lung 2084 samples. O 4 etT levels were significantly increased in smokers as compared with non-smokers and the levels correlated with aromatic-DNA adduct levels, indicating that both originate from cigarette smoke as the main source of exposure. Although active removal of O 4 etT from human DNA was reported (21), the repair mechanisms have not yet been elucidated. The current evidence suggests that O 4 etT is only poorly repaired by O 6 -alkylguanine-DNA-alkyltransferase (12) . Nucleotide excision repair seems to be involved (12, 22) , which is in agreement with the observed close relationship between O 4 etT and PAH-DNA adducts in the present study, as bulky PAH-DNA adducts are also repaired by nucleotide excision repair.
Direct comparison of O 4 etT and BPDE-DNA adducts normalized to total nucleotides, showed that both adducts were equally abundant in lung DNA of smokers (Table II) , and therefore the highly promutagenic O 4 etT may contribute equally to the increased genomic instability and increased cancer risk in smokers. Ethylating compounds are rare as environmental contaminants, but they were undoubtedly found in cigarette smoke (such as NDEA, 0.1-28 ng/cigarette; 23). Increased urinary excretion of N-ethylated adenine has been reported for smokers as compared with non-smokers (9) (10) (11) and the measurement of O 4 etT was therefore expected to offer a highly specific DNA modification to assess exposure to tobacco smoke. Until now, other types of carcinogen-DNA adducts have been used for this purpose, but due to their ubiquitous presence in the environment it could not be established from what source the carcinogens originate. For example, PAH occur in cigarette smoke, but can also be found in large quantities in food products. Oral and inhalation exposure to these compounds might both lead to detectable DNA adducts in lung tissue (24), and are thus thought to be unspecific for cigarette smoke. In the present study, we also have detected O 4 etT and PAH-DNA adducts in lung DNA of non-smokers. The source of these background levels could be the environment, environmental tobacco smoke or both. We could neither confirm nor exclude a role of ETS, due to limited exposure data of these patients. NDEA levels were found to be up to 40 times higher in side stream cigarette smoke as compared with main stream smoke (7) . Also, in studies on the urinary excretion of ethylated DNA bases (9-11) and in a study on the ethylation of hemoglobin (25) , background levels were observed in non-smoking subjects. Recently, the ethylation and methylation of N-terminal valine of hemoglobin was investigated (25) and a difference was found between smokers and non-smokers for ethyl-valine but not for methyl-valine. Similar results were reported for O 4 -ethyl-and O 4 -methylthymidine in human lung DNA (26) . These observations indicate that measuring DNA ethylation is more specific for cigarette smoke exposure than methylation. Surprisingly, no effect of smoking was found on the formation of etheno-DNA adducts, which is not in line with previous studies that found slightly elevated 8-hydroxy-deoxyguanosine levels (~1.5-fold) as marker for oxidative stress in cigarette smokers (27) . Most subjects in the present study reported to have stopped smoking at least 1 week before surgery. Therefore, effective DNA repair of etheno-DNA adducts may explain why we did not see a difference between smokers and nonsmokers. Our data also indicate that lung tissue is well protected against LPO induced by exogenous radicals, because the levels of background etheno-DNA adducts as reported in this study, were lower as compared with the levels reported for other human tissues, such as colon-epithelium, liver, pancreas, oesophagus and leucocytes (14) . Still, in some individuals high levels of etheno-DNA adducts were found, which could be due to increased formation or high persistence (e.g. poor repair) of the adducts. Individuals may significantly differ in their effectivity for removal of εdA and εdC, because the εdC:εdA ratio ranged from 0.1 to 7.5 (data not shown); εdA is repaired by 3-methyladenine DNA glycosylase, whereas εdC is repaired by a mismatch specific thymidine-DNA glycosylase (28) . Highest etheno-DNA adduct levels were found in non-smoking lung cancer subjects with low levels of PAH-DNA adducts or O 4 etT, suggesting that ε-DNA adducts may be involved in the onset or progression of lung cancer in nonsmoking subjects. However, more studies are necessary to find biological reasons and implications of the large inter-individual differences in the levels of etheno-bridged DNA bases. Table III shows a brief summary of major DNA adduct types detected in human lung DNA. Studies reporting adduct levels in both smokers and non-smokers were included. Though higher adduct levels were reported for 8-hydroxy-dG in human lung, only DNA adducts by ethylating compounds (i.e. O 4 etT and O 6 -ethyl-dG), bulky PAH-DNA adducts, BPDE-DNA and the HPB-releasing adducts were found to be Ͼ2-fold increased (range 2-14-fold) in smokers as compared with non-smokers, suggesting that these adduct types are derived from tobacco smoke carcinogens and can be used as biomarkers for exposure to cigarette smoke. Overall cumulative levels of these adducts were 48.7 and 20.1 base modifications/10 8 nucleotides for smokers and non-smokers, respectively. We conclude that in addition to DNA adducts derived from PAH and TSNA (29) , miscoding O 4 etT lesions are formed by cigarette smoke that contribute to the increased genomic instability and lung cancer risk in smokers.
